virtual Sample Inventory Management (vSIM)
virtual Sample Inventory Management (vSIM)
virtual Sample Inventory Management with Precision
Keep track of clinical samples and their derivatives across sites, labs, and repositories.
virtual sample inventory management (vSIM) that maximizes your insight
Using QuartzBio, we can track individual samples across different labs and sites, providing 24/7 access to a master sample inventory and robust reporting that expedites on-study decision-making and enhances collaboration.
- Gain forward-looking visibility into expected sample collection, including as sample schedules evolve
- Evaluate performance trends quickly and monitor site-level sample QC metrics, elevating issues for timely course correction
- Detect discrepancies early with dynamic dashboards and a collaborative interface
- Integrate and QC results data to develop a comprehensive exploratory data asset
QuartzBio is designed for rapid startup and can even be deployed on in-progress studies.
Contact us to learn how vSIM can support your trial
Contact us to learn how vSIM can support your trial
Related services
Global Clinical Trial Footprint
Sample processing labs, clinical trial sites and offices in five continents provide the clinical reach and scale to manage complex global programs.
Clinical Development Strategy
Tailored strategies consider the scientific, regulatory, and commercial factors that shape each trial, mitigating risk and advancing the development pathway.
Clinical Trial Design
Advanced trial-design approaches—including basket, umbrella, and adaptive trials—deliver biomarker driven clinical research. Deep experience in these highly complex trial designs maximizes both insights and efficiency.
Biostatistics
Seasoned biostatisticians and statistical programmers deliver insight into every trial phase, from study design to regulatory submissions, all backed by meticulous documentation and data monitoring.
Clinical Sample Management
Sample inventories from a global network of labs supply real-time processing in 55 countries; consolidated data from central labs, screening labs, and specialty labs with clinical data create actionable reports.
